sorbitol has been researched along with Diabetic Angiopathies in 47 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Excerpt | Relevance | Reference |
---|---|---|
"Glaucoma is a leading cause of blindness." | 2.47 | Clinical and experimental links between diabetes and glaucoma. ( Bui, BV; Vingrys, AJ; Wong, VH, 2011) |
"Mononeuritis (or mononeuritis multiplex) seems to be the result of ischaemia due to intrinsic or extrinsic (altered coagulability) vascular disease." | 2.37 | [Pathogenesis of diabetic neuropathies]. ( Arlot, S; Lalau, JD; Quichaud, J, 1985) |
"Methylguanidine was only approximately 7% as effective as aminoguanidine as an inhibitor of AGE formation from L-lysine and G6P; both compounds were poor inhibitors of AR." | 1.29 | Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. ( Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG, 1993) |
"Diabetes mellitus is an important risk factor for coronary heart disease and cerebral vascular disease." | 1.29 | [Diabetes mellitus as a risk factor for arteriosclerosis]. ( Kasuga, M; Maeda, E; Yoshino, G, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (51.06) | 18.7374 |
1990's | 15 (31.91) | 18.2507 |
2000's | 5 (10.64) | 29.6817 |
2010's | 1 (2.13) | 24.3611 |
2020's | 2 (4.26) | 2.80 |
Authors | Studies |
---|---|
Wang, S | 1 |
Jiao, F | 1 |
Border, JJ | 1 |
Fang, X | 1 |
Crumpler, RF | 1 |
Liu, Y | 1 |
Zhang, H | 1 |
Jefferson, J | 1 |
Guo, Y | 1 |
Elliott, PS | 1 |
Thomas, KN | 1 |
Strong, LB | 1 |
Urvina, AH | 1 |
Zheng, B | 1 |
Rijal, A | 1 |
Smith, SV | 1 |
Yu, H | 1 |
Roman, RJ | 1 |
Fan, F | 1 |
Papachristoforou, E | 1 |
Lambadiari, V | 1 |
Maratou, E | 1 |
Makrilakis, K | 1 |
Wong, VH | 1 |
Bui, BV | 1 |
Vingrys, AJ | 1 |
Tilton, RG | 3 |
Hosojima, H | 2 |
Hotta, N | 1 |
Murphie, P | 1 |
Nakamura, J | 1 |
Brownlee, M | 3 |
Cerami, A | 1 |
Ward, JD | 1 |
Lowe, WL | 1 |
Florkiewicz, RZ | 1 |
Yorek, MA | 1 |
Spanheimer, RG | 1 |
Albrecht, BN | 1 |
Chang, K | 4 |
Hasan, KS | 1 |
Smith, SR | 1 |
Petrash, JM | 1 |
Misko, TP | 1 |
Moore, WM | 1 |
Currie, MG | 1 |
Corbett, JA | 1 |
McDaniel, ML | 1 |
Yamaoka, T | 1 |
Nishimura, C | 1 |
Yamashita, K | 1 |
Itakura, M | 1 |
Yamada, T | 1 |
Fujimoto, J | 1 |
Kokai, Y | 1 |
Nyengaard, JR | 1 |
Van den Enden, M | 1 |
Ido, Y | 2 |
Williamson, JR | 5 |
Guillausseau, PJ | 1 |
Maeda, E | 1 |
Yoshino, G | 1 |
Kasuga, M | 1 |
Kilo, C | 4 |
De la Cruz, JP | 1 |
Maximo, MA | 1 |
Blanco, E | 1 |
Moreno, A | 1 |
Sánchez de la Cuesta, F | 1 |
Daumerie-Goffinet, C | 1 |
Lambert, AE | 1 |
Balasse, EO | 1 |
Tsvetanov, L | 1 |
Ruderman, NB | 1 |
Kawazu, S | 1 |
Tomono, S | 1 |
Wakasugi, M | 1 |
Noguchi, T | 1 |
Inoue, M | 1 |
Tawata, M | 1 |
Shindo, H | 1 |
Onaya, T | 1 |
Hasegawa, G | 1 |
Tsutsumi, Y | 1 |
Aoki, S | 1 |
Sawada, M | 1 |
Setoguchi, J | 1 |
Nakamura, N | 1 |
Nakano, K | 1 |
Kondo, M | 1 |
Kanatsuna, T | 1 |
Ostrow, E | 1 |
Eades, D | 1 |
Allison, W | 1 |
Sherman, WR | 2 |
Kowluru, R | 1 |
Bitensky, MW | 1 |
Kowluru, A | 1 |
Dembo, M | 1 |
Keaton, PA | 1 |
Buican, T | 1 |
Mann, J | 1 |
Koh, MS | 1 |
Misch, KJ | 1 |
Yuen, CT | 1 |
Rhodes, EL | 1 |
Lalau, JD | 1 |
Arlot, S | 1 |
Quichaud, J | 1 |
Kador, PF | 1 |
Kinoshita, JH | 2 |
Sharpless, NE | 1 |
Rowold, E | 1 |
Marvel, J | 1 |
Tomlinson, M | 1 |
Ackermann, KE | 1 |
Beaumont, P | 2 |
Schofield, PJ | 1 |
Hollows, FC | 1 |
Wiows, FC | 1 |
Steinbeck, AW | 1 |
Williams, JF | 1 |
Gabbay, KH | 1 |
Wieland, OH | 2 |
Winegrad, AI | 1 |
Morrison, AD | 1 |
Clements, RS | 1 |
Lekishvili, VP | 1 |
Mehnert, H | 1 |
Draznin, NM | 1 |
Fiser, RH | 1 |
Dawidowicz, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes[NCT05478707] | Phase 2 | 64 participants (Anticipated) | Interventional | 2023-10-05 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
19 reviews available for sorbitol and Diabetic Angiopathies
Article | Year |
---|---|
Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathi | 2020 |
Clinical and experimental links between diabetes and glaucoma.
Topics: Animals; Apoptosis; Cell Death; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Di | 2011 |
Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF.
Topics: Animals; Capillary Permeability; Cell Hypoxia; Diabetic Angiopathies; Endothelial Growth Factors; Gl | 2002 |
[Erythrocyte sorbitol, sorbitol dehydrogenase (SDH), and glyceraldehyde reductase (GAR) in diabetes mellitus].
Topics: Animals; Biomarkers; Diabetes Mellitus; Diabetic Angiopathies; Erythrocytes; Glucose; Humans; Hyperg | 2002 |
[Risk factors for diabetic complications: Abnormality of polyol metabolism].
Topics: Aldehyde Reductase; Animals; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; F | 2002 |
Microvascular disease aetiology in diabetic foot ulceration.
Topics: Adenosine Triphosphate; Aldehyde Reductase; Basement Membrane; Blood Flow Velocity; Diabetic Angiopa | 2001 |
[Role of polyol pathway in pathogenesis of diabetic microangiopathy].
Topics: Aldehyde Reductase; Animals; Diabetic Angiopathies; Fructose; Glucose; Glycation End Products, Advan | 2005 |
The biochemistry of the complications of diabetes mellitus.
Topics: Animals; Axonal Transport; Basement Membrane; Blood Platelets; Blood Proteins; Cataract; Diabetes Co | 1981 |
[Preventive treatment of diabetic microangiopathy: blocking the pathogenic mechanisms].
Topics: Aldehyde Reductase; Animals; Diabetic Angiopathies; Glucose; Glycosylation; Humans; Hyperglycemia; O | 1994 |
[Diabetic microangiopathies].
Topics: Basement Membrane; Blood Viscosity; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies | 1978 |
[Possibilities of preventing diabetic angiopathy (pathogenetic factors in angiopathy)].
Topics: Animals; Diabetic Angiopathies; Epinephrine; Fructose; Glucagon; Growth Hormone; Humans; Hyperglycem | 1976 |
Glucose and diabetic vascular disease.
Topics: Animals; Diabetic Angiopathies; Diglycerides; Extracellular Matrix; Glucose; Humans; Hyperglycemia; | 1992 |
Dietary advice for diabetics: a perspective from the United Kingdom.
Topics: Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Diet, Sodium-Restricted; Dietary Carbohydra | 1986 |
Value of glucose control in preventing complications of diabetes.
Topics: Adult; Animals; Blood Glucose; Blood Pressure; Blood Vessels; Body Weight; Collagen; Diabetes Compli | 1985 |
[Pathogenesis of diabetic neuropathies].
Topics: Animals; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Energy Metabolism; Humans; | 1985 |
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
Topics: Aldehyde Reductase; Animals; Binding Sites; Blood Glucose; Cataract; Chemical Phenomena; Chemistry; | 1985 |
[New theories of the pathogenesis of diabetic neuropathies].
Topics: Animals; Carbohydrate Metabolism; Demyelinating Diseases; Diabetes Mellitus, Experimental; Diabetic | 1974 |
[Pathogenesis and prophylaxis of diabetic micro-angiopathy (author's transl)].
Topics: Alcohol Oxidoreductases; Animals; Basement Membrane; Cell Membrane; Collagen; Diabetes Mellitus, Exp | 1974 |
[Diabetic cataract and modern views on the etiology and pathogenesis of vascular complications during diabetes].
Topics: Age Factors; Cataract; Cataract Extraction; Diabetes Complications; Diabetes Mellitus, Type 1; Diabe | 1971 |
1 trial available for sorbitol and Diabetic Angiopathies
Article | Year |
---|---|
Relationship between erythrocyte sorbitol content and diabetic microangiopathy in patients with non-insulin-dependent diabetes mellitus: the study of a diet loading test.
Topics: Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet; Erythrocyte | 1991 |
27 other studies available for sorbitol and Diabetic Angiopathies
Article | Year |
---|---|
Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals.
Topics: Animals; Arterioles; Blood-Brain Barrier; Cells, Cultured; Cerebrovascular Circulation; Cognition; D | 2022 |
[The problem of the complications of diabetes].
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellit | 1984 |
Regulation of growth factor mRNA levels in the eyes of diabetic rats.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Retino | 1995 |
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; B | 1993 |
Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.
Topics: Aldehyde Reductase; Animals; Base Sequence; Blotting, Southern; Blotting, Western; Diabetic Angiopat | 1995 |
Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Neuropathies; Eye; Fructos | 1995 |
[Diabetes mellitus as a risk factor for arteriosclerosis].
Topics: Arteriosclerosis; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Glycosylation; H | 1993 |
Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction.
Topics: Animals; Blood Flow Velocity; Blood Glucose; Capillary Permeability; Cattle; Diabetes Mellitus, Expe | 1996 |
Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Adenosine Diphosphate; Adult; Animals; Aorta; Blood Glucose | 1997 |
[Physiopathology of chronic complications in diabetes: therapeutic implications].
Topics: Adult; Aged; Arteriosclerosis; Blood Platelets; Diabetes Complications; Diabetic Angiopathies; Diabe | 1979 |
Glycosylation of proteins and microangiopathy.
Topics: Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diglycerides; Dogs; Gl | 1992 |
[Diabetic microangiopathy--its biochemical bases].
Topics: Animals; Basement Membrane; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Glu | 1991 |
Effects of aldose reductase inhibitors on prostacyclin (PGI2) synthesis by aortic rings from rats with streptozotocin-induced diabetes.
Topics: Aldehyde Reductase; Animals; Aorta, Thoracic; Blood Glucose; Chalcone; Chalcones; Diabetes Mellitus, | 1991 |
[Clinical significance of erythrocyte sorbitol, sorbitol dehydrogenase and glyceraldehyde reductase in diabetic complications].
Topics: Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Humans; L-Iditol 2-Dehydrogenase; Sorbitol; | 1990 |
Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.
Topics: Aldehyde Reductase; Animals; Capillary Permeability; Diabetic Angiopathies; Glucose; Glycosylation; | 1990 |
Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy.
Topics: Adenosine Triphosphate; Animals; Cytosol; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Er | 1989 |
Accumulation of sorbitol in endothelial cells--a possible cause of diabetic microangiopathy.
Topics: Cells, Cultured; Diabetic Angiopathies; Endothelium; Female; Glucose; Humans; Kinetics; Muscle, Smoo | 1986 |
Diabetes-induced increases in vascular permeability and changes in granulation tissue levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinil.
Topics: Adolescent; Animals; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Angiopathies; | 1986 |
Growth hormone, sorbitol, and diabetic capillary disease.
Topics: Capillaries; Diabetic Angiopathies; Diabetic Retinopathy; Fatty Acids; Glucose; Growth Hormone; Huma | 1971 |
Growth hormone, sorbitol, and diabetic capillary disease.
Topics: Blood Glucose; Diabetic Angiopathies; Glucose; Growth Hormone; Humans; Osmotic Fragility; Sorbitol | 1971 |
[Pathobiochemistry of the late-onset diabetic syndrome].
Topics: Age Factors; Alcohol Oxidoreductases; Animals; Basement Membrane; Cataract; Diabetes Mellitus; Diabe | 1974 |
Polyol pathway activity in aorta.
Topics: Animals; Aorta; Arteriosclerosis; Diabetic Angiopathies; Fructose; Fructose-Bisphosphate Aldolase; G | 1973 |
[Pathobiochemistry of the late-onset diabetic syndrome].
Topics: Animals; Carbohydrates; Cataract; Cell Membrane; Chemical Phenomena; Chemistry; Diabetes Complicatio | 1974 |
[Pathogenesis of angio- and neuropathies in patients with diabetes mellitus].
Topics: Blood Vessels; Cataract; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic | 1973 |
Lipid metabolism, the polyol pathway and vascular complications.
Topics: Diabetes Mellitus; Diabetic Angiopathies; Female; Glucose; Humans; Infant, Newborn; Infant, Newborn, | 1973 |
Glucose-dependent changes in aortic wall metabolism.
Topics: Animals; Aorta; Blood Glucose; Diabetic Angiopathies; Humans; Hyperglycemia; Rabbits; Sorbitol | 1970 |
Factors in diabetic microangiopathy.
Topics: Diabetic Angiopathies; Diabetic Retinopathy; Fatty Acids, Nonesterified; Humans; Retinal Vessels; So | 1970 |